2012
DOI: 10.1136/ejhpharm-2012-000074.48
|View full text |Cite
|
Sign up to set email alerts
|

Off-label oral transmucosal fentanyl citrate analgesia for bone fracture alignment in children

Abstract: Background Oral transmucosal fentanyl citrate is indicated for the treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. Purpose To evaluate off-label transmucosal fentanyl citrate use for bone fracture alignment in children. Materials and methods In December of 2010 the Pharmacy and Therapeutics Committee approved a protocol for off-label transmucosal fentanyl citrate use for bone fracture alignment in children older than 3 years… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles